Cargando…

Proton Pump Inhibitors and the Risk of Adverse Cardiac Events

BACKGROUND: Recent evidence suggests that proton pump inhibitors (PPIs) might be linked with adverse cardiac events, but a causal relationship is unproven. METHODS: We applied the self-matched case series method to two studies using population-based health care data from Ontario, Canada between 1996...

Descripción completa

Detalles Bibliográficos
Autores principales:	Juurlink, David N., Dormuth, Colin R., Huang, Anjie, Hellings, Chelsea, Paterson, J. Michael, Raymond, Colette, Kozyrskyj, Anita, Moride, Yola, Macdonald, Erin M., Mamdani, Muhammad M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873988/ https://www.ncbi.nlm.nih.gov/pubmed/24386430 http://dx.doi.org/10.1371/journal.pone.0084890

Ejemplares similares

Proton Pump Inhibitors and Hospitalization with Hypomagnesemia: A Population-Based Case-Control Study
por: Zipursky, Jonathan, et al.
Publicado: (2014)

Extended-release nifedipine and the risk of intestinal obstruction: a population-based study
por: Juurlink, David N, et al.
Publicado: (2014)

Tramadol and the risk of seizure: nested case-control study of US patients with employer-sponsored health benefits
por: Morrow, Richard L, et al.
Publicado: (2019)

Prescription Stimulant Use and Hospitalization for Psychosis or Mania: A Population-Based Study
por: Cressman, Alex M., et al.
Publicado: (2015)

Human Papillomavirus Vaccination and Premature Ovarian Failure: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System
por: Tatang, Collins, et al.
Publicado: (2021)

Commentary: The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux-A Prospective Longitudinal Interventional Study
por: Drall, Kelsea M., et al.
Publicado: (2018)

Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study
por: Juurlink, David N, et al.
Publicado: (2009)

Implementation of Interventions and Policies on Opioids and Awareness of Opioid-Related Harms in Canada: A Multistage Mixed Methods Descriptive Study
por: Goyer, Camille, et al.
Publicado: (2022)

Impact of the COVID-19 Pandemic on Patterns of Prescription Opioid Use: A Retrospective Cohort Study of Adults Without a Cancer Diagnosis Initiating Opioids Using Administrative Claims Data
por: Castilloux, Anne-Marie, et al.
Publicado: (2022)

Global Incidence and Prevalence of Gaucher Disease: A Targeted Literature Review
por: Castillon, Genaro, et al.
Publicado: (2022)

Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study
por: Antoniou, Tony, et al.
Publicado: (2011)

A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors
por: Cressman, Alex M, et al.
Publicado: (2015)

Impact of proton pump inhibitors on the onset of gastrointestinal immune‐related adverse events during immunotherapy
por: Lasagna, Angioletta, et al.
Publicado: (2023)

High daily doses of benzodiazepines among Quebec seniors: prevalence and correlates
por: Egan, Mary Y, et al.
Publicado: (2001)

Impact of schizophrenia relapse definition on the comparative effectiveness of oral versus injectable antipsychotics: A systematic review and meta‐analysis of observational studies
por: Cristarella, Tiffany, et al.
Publicado: (2022)

Adverse Effects of Proton Pump Inhibitors—Evidence and Plausibility
por: Fossmark, Reidar, et al.
Publicado: (2019)

Adverse Effects Associated with Proton Pump Inhibitor Use
por: Yibirin, Marcel, et al.
Publicado: (2021)

Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis
por: Filion, Kristian B, et al.
Publicado: (2014)

Maternal opioid treatment after delivery and risk of adverse infant outcomes: population based cohort study
por: Zipursky, Jonathan S, et al.
Publicado: (2023)

2480. Real-World Effectiveness of the Live Zoster Vaccine in Preventing Herpes Zoster: A Systematic Review
por: Saddier, Patricia, et al.
Publicado: (2018)

Proton Pump Inhibitors and the Risk for Fracture at Specific Sites: Data Mining of the FDA Adverse Event Reporting System
por: Wang, Liwei, et al.
Publicado: (2017)

A pharmacovigilance study of association between proton pump inhibitor and dementia event based on FDA adverse event reporting system data
por: Wu, Bin, et al.
Publicado: (2021)

Epidemiology of Asymptomatic Pre-heart Failure: a Systematic Review
por: Bergamasco, Aurore, et al.
Publicado: (2022)

The Burden of Opioid-Related Mortality in the United States
por: Gomes, Tara, et al.
Publicado: (2018)

Population-based cohort study: proton pump inhibitor use during pregnancy in Sweden and the risk of maternal and neonatal adverse events
por: Breddels, Esmee M., et al.
Publicado: (2022)

Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population based study
por: Fralick, Michael, et al.
Publicado: (2014)

Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors
por: Maideen, Naina Mohamed Pakkir
Publicado: (2023)

Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case–control study
por: Moride, Yola, et al.
Publicado: (2005)

Von Willebrand Disease Epidemiology, Burden of Illness and Management: A Systematic Review
por: Du, Ping, et al.
Publicado: (2023)

Association of direct oral anticoagulant-proton pump inhibitor cotherapy with adverse outcomes: protocol for a population-based cohort study
por: Wang, Mei, et al.
Publicado: (2022)

Reformulation of controlled-release oxycodone and pharmacy dispensing patterns near the US–Canada border
por: Gomes, Tara, et al.
Publicado: (2012)

Assessment of Stimulant Use and Cardiovascular Event Risks Among Older Adults
por: Tadrous, Mina, et al.
Publicado: (2021)

Programmable Infusion Pumps in ICUs: An Analysis of Corresponding Adverse Drug Events
por: Nuckols, Teryl K., et al.
Publicado: (2007)

Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory
por: Makunts, Tigran, et al.
Publicado: (2019)

Risk Management for the 21st Century: Current Status and Future Needs
por: Mouchantaf, Rania, et al.
Publicado: (2021)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada
por: Burden, A. M., et al.
Publicado: (2011)

Measuring the Burden of Opioid-related Mortality in Ontario, Canada
por: Gomes, Tara, et al.
Publicado: (2018)

Hepatotoxicity-Related Adverse Effects of Proton Pump Inhibitors: A Cross-Sectional Study of Signal Mining and Analysis of the FDA Adverse Event Report System Database
por: Zeng, Yifan, et al.
Publicado: (2021)

A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors
por: Yu, Li-Yuan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dmoaou9cv80ol2ubd5vk3rvjb2